Arcus Biosciences, Inc.
(NYSE : RCUS)

( )
RCUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.76%167.520.0%$1572.37m
NVAXNovavax, Inc. -2.13%90.3678.2%$615.65m
AMGNAmgen, Inc. -1.04%228.901.4%$505.63m
BIIBBiogen, Inc. -2.12%225.911.8%$493.88m
GILDGilead Sciences, Inc. -1.82%67.811.0%$457.06m
BNTXBioNTech SE -3.17%156.530.0%$428.66m
ILMNIllumina, Inc. -1.02%380.443.3%$383.57m
REGNRegeneron Pharmaceuticals, Inc. -0.60%614.382.7%$380.02m
VRTXVertex Pharmaceuticals, Inc. -0.97%228.611.9%$333.31m
SNSSSunesis Pharmaceuticals, Inc. -4.17%2.760.7%$192.93m
EXASEXACT Sciences Corp. -0.13%76.0317.9%$166.25m
ARNAArena Pharmaceuticals, Inc. -0.55%91.0113.7%$134.19m
INCYIncyte Corp. -0.03%74.762.4%$128.59m
ALNYAlnylam Pharmaceuticals, Inc. -0.22%138.318.2%$127.21m
BBIOBridgeBio Pharma, Inc. -2.05%11.460.0%$102.72m

Company Profile

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.